Found 256 matching trials
A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
PHASE3The main purpose of this study is to evaluate the safety and efficacy of on...
Location
The Second People's Hospital of Hefei
Efficacy and Safety of Platelet-rich Plasma, Metformin and Cryotherapy in Treatment of Non-genital Warts
PHASE21. Evaluation of the efficacy and safety of intralesional injection of auto...
Location
Multiple Locations
Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes
PHASE1This study investigated a 4-week adjunctive therapy of either a GLP-1 analo...
Location
Profil Institut für Stoffwechselforschung GmbH
A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine
PHASE2This study compares insulin 287 (a possible new medicine) to insulin glargi...
Location
Novo Nordisk Investigational Site
Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients
PHASE2This was a four month dose ranging study followed by a 24 to 48 month exten...
Location
Anasazi Internal Medicine
Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga
PHASE4The purpose of the study is to determine whether in patients with early typ...
Location
University of Calgary
Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics
PHASE4People with both hypertension and diabetes have a higher chance of developi...
Location
Dr. Pokov's Polyclinic. 6821 Reisterstown Road Suite 206
Sugar Challenge Study
N/AThis is a longitudinal study involving use of the January App which collect...
Evaluation of Insulin Glargine in Combination With Sitagliptin in Type 2 Diabetes Patients: EASIE Extension Trial
PHASE3This study was the extension of the LANTU\_C\_02761 study named EASIE and i...
Location
Sanofi-Aventis Administrative Office
The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients
PHASE3This is a 28-week, multi-center, randomized, double-blind, placebo-controll...
Location
Diabeteszentrum Oldenburg